重症坏死性软组织感染患者的医疗轨迹:基于大巴黎大学医院临床数据仓库的多中心回顾性队列研究
该多中心回顾性队列纳入大巴黎地区13家医院2015年1月1日至2019年12月31日期间ICU收治的经手术确诊坏死性软组织感染患者170例,描述其医疗轨迹并分析复杂病程相关因素。ICU住院中位8(3–17)天、住院中位37(14–71)天,入院至首次清创中位1(0–2)天,69.9%患者再次手术,中位额外清创1(0–3)次,52.4%需院际转运。80.2%病程中出现器官衰竭,51.8%需有创机械通气、77.2%需血管活性药物、27.7%需肾脏替代治疗;ICU病死率21.8%、住院病死率28.8%。免疫功能低下患者(n=43)ICU病死率37.2% vs 非免疫功能低下者(n=127)16.5%(p=0.009),住院病死率53.5% vs 20.5%(p<0.001)。复杂病程相关因素为多种微生物感染(aOR=3.18,95%CI 1.37–7.35;p=0.007)、菌血症(aOR=3.29,95%CI 1.14–9.52;p=0.028)及较高SAPS II评分(aOR=1.05,95%CI 1.02–1.07;p<0.0001);62.3%患者在6个月内再住院。
要点
- 170例经手术确诊的坏死性软组织感染患者中,ICU住院中位8(3–17)天、住院中位37(14–71)天,80.2%病程中出现器官衰竭。
- 51.8%需有创机械通气、77.2%需血管活性药物、27.7%需肾脏替代治疗;ICU病死率21.8%、住院病死率28.8%。
- 入院至首次手术清创中位1(0–2)天,但69.9%患者需再次手术,中位额外清创1(0–3)次,52.4%需院际转运。
- 免疫功能低下患者(n=43)ICU病死率37.2% vs 非免疫功能低下者(n=127)16.5%(p=0.009),住院病死率53.5% vs 20.5%(p<0.001)。
- 复杂病程与多种微生物感染(aOR=3.18,95%CI 1.37–7.35;p=0.007)、菌血症(aOR=3.29,95%CI 1.14–9.52;p=0.028)及较高SAPS II评分(aOR=1.05,95%CI 1.02–1.07;p<0.0001)相关;62.3%患者6个月内再住院。
适用人群与场景
- 大巴黎地区13家医院ICU于2015年1月1日至2019年12月31日收治的经手术确诊的坏死性软组织感染成人患者170例。
- 亚组包括腹会阴部坏死性软组织感染33例、免疫功能低下患者43例。
研究设计与关键结果
- 研究类型为多中心回顾性观察性队列研究,纳入13家医院170例经手术确诊的坏死性软组织感染ICU患者。
- ICU住院中位8(3–17)天,住院中位37(14–71)天;入院至首次手术清创中位1(0–2)天。
- 69.9%患者再次手术,中位额外清创1(0–3)次;52.4%患者需院际转运。
- 80.2%患者ICU病程中出现器官衰竭,51.8%需有创机械通气,77.2%需血管活性药物支持,27.7%需肾脏替代治疗。
- ICU病死率21.8%,住院病死率28.8%。
- 腹会阴部坏死性软组织感染患者(n=33)与其他部位患者(n=137)在ICU或住院病死率上无显著差异。
- 免疫功能低下患者(n=43)较非免疫功能低下患者(n=127)ICU病死率更高(37.2% vs 16.5%,p=0.009),住院病死率更高(53.5% vs 20.5%,p<0.001)。
- 复杂病程相关因素:多种微生物感染aOR=3.18(95%CI 1.37–7.35),p=0.007;菌血症aOR=3.29(95%CI 1.14–9.52),p=0.028;较高SAPS II评分aOR=1.05(95%CI 1.02–1.07),p<0.0001;62.3%患者6个月内再住院。
证据类型、等级与局限
- 证据类型:多中心回顾性观察性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,坏死性软组织感染患者需要复杂管理且是医疗资源的主要消耗者,约三分之二患者经历复杂住院病程,该病程与较高SAPS II评分、多种微生物感染及菌血症相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Necrotizing skin and soft tissue infections (NSTIs) are rare but serious and rapidly progressive infections characterized by necrosis of subcutaneous tissue, fascia and even muscle. The care pathway of patients with NSTIs is poorly understood. A better characterization of the care trajectory of these patients and a better identification of patients at risk of a complicated evolution, requiring prolonged hospitalization, multiple surgical re-interventions, or readmission to the intensive care unit (ICU), is an essential prerequisite to improve their care. The main objective of this study is to obtain large-scale data on the care pathway of these patients. We performed a retrospective multicenter observational cohort study in 13 Great Paris area hospitals, including patients hospitalized between January 1, 2015 and December 31, 2019 in the ICU for surgically confirmed NSTIs.
RESULTS: 170 patients were included. The median duration of stay in ICU and hospital was 8 (3-17) and 37 (14-71) days, respectively. The median time from admission to first surgical debridement was 1 (0-2) day but 69.9% of patients were re-operated with a median of 1 (0-3) additional debridement. Inter-hospital transfer was necessary in 52.4% of patients. 80.2% of patients developed organ failures during the course of ICU stay with 51.8% of patients requiring invasive mechanical ventilation, 77.2% needing vasopressor support and 27.7% renal replacement therapy. In-ICU and in-hospital mortality rates were 21.8% and 28.8%, respectively. There was no significant difference between patients with abdomino-perineal NSTIs (n = 33) and others (n = 137) in terms of in-hospital or ICU mortality. Yet, immunocompromised patients (n = 43) showed significantly higher ICU and in-hospital mortality rates than non-immunocompromised patients (n = 127) (37.2% vs. 16.5%, p = 0.009, and 53.5% vs. 20.5%, p < 0.001). Factors associated with a complicated course were the presence of a polymicrobial infection (adjusted odds ratio [aOR = 3.18 (1.37-7.35); p = 0.007], of a bacteremia [aOR = 3.29 (1.14-9.52); p = 0.028] and a higher SAPS II score [aOR = 1.05 (1.02-1.07); p < 0.0001]. 62.3% of patients were re-hospitalized within 6 months.
CONCLUSION: In this retrospective multicenter study, we showed that patients with NSTI required complex management and are major consumers of care. Two-thirds of them underwent a complicated hospital course, associated with a higher SAPS II score, a polymicrobial NSTI and a bacteremia.
参考来源
- Windsor C, Hua C, De Roux Q, et al. Healthcare trajectory of critically ill patients with necrotizing soft tissue infections: a multicenter retrospective cohort study using the clinical data warehouse of Greater Paris University Hospitals. Ann Intensive Care. 2022. PMID: 36538244. doi:10.1186/s13613-022-01087-5
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。